Confusing Cochrane reviews on treatment in multiple sclerosis

Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.

The Cochrane database of systematic reviews·2026

The Diagnostic Accuracy of the Second Revision of the European Academy of Neurology/Peripheral Nerve Society Guideline for Diagnosing Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

European journal of neurology·2026

Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.

Multiple sclerosis and related disorders·2026

The complex lipidome as a driver of tissue-specific pathology in adrenoleukodystrophy.

Molecular neurodegeneration·2026

NKX2-1 Downstream Regulatory Structural Variants Explain a Substantial Proportion of Molecular Diagnoses in Patients With Benign Hereditary Chorea.

Movement disorders : official journal of the Movement Disorder Society·2026

Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

European journal of neurology·2026

Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial.

The Lancet. Neurology·2026

Deep brain stimulation for the treatment of patients with dystonia: advances towards network-based personalised care.

The Lancet. Neurology·2026

The role of the gut microbiome in mediating neuroinflammation in immune-based neurological disorders.

The Lancet. Neurology·2026

Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications.

The Lancet. Neurology·2026

Survival estimates and their predictors in genetic frontotemporal dementia: an international, retrospective, cohort study.

The Lancet. Neurology·2026

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

The Lancet. Neurology·2026

Seeing to Connect: How Visual and Auditory Channels Shape Empathic Interactions.

Personality & social psychology bulletin·2026

Smoking-related stigma as a barrier to participation in lung cancer screening.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026

'Better Conversations with Primary Progressive Aphasia and other rare dementias (BCPPA plus)' telehealth communication partner training programme: protocol for an NHS embedded randomised controlled feasibility and implementation study.

BMJ open·2026

Understanding social anxiety in adolescents who stutter: A multi-informant study of the roles of stuttering severity, parenting styles, social participation and speech avoidance.

Journal of communication disorders·2026

Real-time emotional dynamics and public discourse on Sina Weibo following the first imported mpox case in mainland China: A sentiment analysis study.

PloS one·2026

A Systematic Review and Meta-Analysis of Audiovisual Multisensory Integration in Schizophrenia Spectrum Disorders.

Multisensory research·2026

Related Experiment Videos

Confusing Cochrane reviews on treatment in multiple sclerosis

Related Concept Videos

Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.

The Diagnostic Accuracy of the Second Revision of the European Academy of Neurology/Peripheral Nerve Society Guideline for Diagnosing Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.

The complex lipidome as a driver of tissue-specific pathology in adrenoleukodystrophy.

NKX2-1 Downstream Regulatory Structural Variants Explain a Substantial Proportion of Molecular Diagnoses in Patients With Benign Hereditary Chorea.

Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial.

Deep brain stimulation for the treatment of patients with dystonia: advances towards network-based personalised care.

The role of the gut microbiome in mediating neuroinflammation in immune-based neurological disorders.

Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications.

Survival estimates and their predictors in genetic frontotemporal dementia: an international, retrospective, cohort study.

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

Seeing to Connect: How Visual and Auditory Channels Shape Empathic Interactions.

Smoking-related stigma as a barrier to participation in lung cancer screening.

'Better Conversations with Primary Progressive Aphasia and other rare dementias (BCPPA plus)' telehealth communication partner training programme: protocol for an NHS embedded randomised controlled feasibility and implementation study.

Understanding social anxiety in adolescents who stutter: A multi-informant study of the roles of stuttering severity, parenting styles, social participation and speech avoidance.

Real-time emotional dynamics and public discourse on Sina Weibo following the first imported mpox case in mainland China: A sentiment analysis study.

A Systematic Review and Meta-Analysis of Audiovisual Multisensory Integration in Schizophrenia Spectrum Disorders.

Related Experiment Videos

Confusing Cochrane reviews on treatment in multiple sclerosis

Related Concept Videos

Related Articles